相似文献
1
What clinicians need to know about antiviral drugs and viral resistance.
Infect Dis Clin North Am. 1997 Dec;11(4):945-67. doi: 10.1016/s0891-5520(05)70399-8.
2
Antiviral therapies in children: has their time arrived?
Pediatr Clin North Am. 2005 Jun;52(3):837-67, vii. doi: 10.1016/j.pcl.2005.02.006.
3
Summary of the III International Consensus Symposium on Combined Antiviral Therapy.
Antiviral Res. 1998 May;38(2):75-93. doi: 10.1016/s0166-3542(98)00021-7.
4
[Antiviral therapy: from influenza to Pfeiffer's disease].
Internist (Berl). 2006 Dec;47(12):1245-50. doi: 10.1007/s00108-006-1721-9.
5
Comparison of antiviral resistance across acute and chronic viral infections.
Antiviral Res. 2018 Oct;158:103-112. doi: 10.1016/j.antiviral.2018.07.020. Epub 2018 Aug 4.
6
Drugs for non-HIV viral infections.
Treat Guidel Med Lett. 2007 Jul;5(59):59-70.
7
Antiviral chemotherapy.
Br J Hosp Med. 1987 Jan;37(1):22, 24-6.
8
Achievements and challenges in antiviral drug discovery.
Antivir Chem Chemother. 2005;16(3):155-68. doi: 10.1177/095632020501600302.
9
Antiviral drugs in pediatrics.
Am J Dis Child. 1989 Nov;143(11):1307-16. doi: 10.1001/archpedi.1989.02150230065025.
10
"The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.
Clin Microbiol Rev. 1994 Jan;7(1):1-13. doi: 10.1128/CMR.7.1.1.
引用本文的文献
1
Antiviral agents in the critically ill child.
Semin Pediatr Infect Dis. 2000 Jan;11(1):35-42. doi: 10.1053/spid.0110035. Epub 2005 Nov 2.
2
Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy.
Clin Microbiol Rev. 2003 Jan;16(1):114-28. doi: 10.1128/CMR.16.1.114-128.2003.
3
Viral capsid mobility: a dynamic conduit for inactivation.
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2274-7. doi: 10.1073/pnas.051598298. Epub 2001 Feb 13.
本文引用的文献
1
Valacyclovir.
Ann Pharmacother. 1997 Feb;31(2):185-91. doi: 10.1177/106002809703100211.
2
Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
J Hosp Infect. 1996 Aug;33(4):235-48. doi: 10.1016/s0195-6701(96)90010-9.
3
Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription.
Antimicrob Agents Chemother. 1996 Mar;40(3):527-40. doi: 10.1128/AAC.40.3.527.
4
Molecular detection of human cytomegalovirus and determination of genotypic ganciclovir resistance in clinical specimens.
Clin Infect Dis. 1995 Oct;21 Suppl 2:S170-3. doi: 10.1093/clinids/21.supplement_2.s170.
5
Clinical significance of drug resistance in human immunodeficiency virus.
Clin Infect Dis. 1995 Oct;21 Suppl 2:S166-9. doi: 10.1093/clinids/21.supplement_2.s166.
6
Cidofovir.
Drugs. 1996 Aug;52(2):225-230; discussion 231. doi: 10.2165/00003495-199652020-00006.
7
Antiretroviral drugs for AIDS.
Lancet. 1996 Sep 21;348(9030):800-3. doi: 10.1016/S0140-6736(95)12333-4.
8
Drug-resistance patterns of saquinavir and other HIV proteinase inhibitors.
AIDS. 1995 Dec;9 Suppl 2:27-S32.
9
Drug resistance in cytomegalovirus: current knowledge and implications for patient management.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12 Suppl 1:S1-22.
10
Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy.
Antiviral Res. 1995 Dec;28(4):281-90. doi: 10.1016/0166-3542(95)00066-6.
Zotero 插件